Background
The COVID‐19 pandemic is the most serious global public health crisis since the 1918 influenza pandemic. This study is the first to assess its mental health impact across the lifespan in ...the United States in adolescents, adults, and health care workers.
Methods
We recruited 4909 participants through an online survey advertising on Facebook and Instagram to assess exposure to COVID‐19 and psychiatric symptoms from April 27 to July 13. We also recruited through the University of Pittsburgh, University of Pittsburgh Medical Center, and other health care systems around Pittsburgh. The primary outcomes were clinically significant depression, anxiety, and posttraumatic stress disorder (PTSD) symptoms, suicidal ideation or behavior, and grief reactions since COVID‐19.
Results
Adolescents were significantly more likely to report moderate to severe symptoms of depression (55% vs. 29%; χ2 = 122, df = 1; p < .001), anxiety (48% vs. 29%; χ2 = 73; df = 1; p < .001), PTSD (45% vs. 33%; χ2 = 12; df = 1; p < .001), suicidal ideation or behavior (38% vs. 16%; χ2 = 117; df = 1; p < .001), and sleep problems (69% vs. 57%; χ2 = 26; df = 1; p < .001) compared to adults. The rates of intense grief reactions among those who lost someone to COVID‐19 was 55%. Loneliness was the most common predictor across outcomes and higher number of hours spent on social media and exposure to media about COVID‐19 predicted depression symptoms and suicidal ideation or behavior in adolescents.
Conclusions
The COVID‐19 pandemic is associated with increased rates of clinically significant psychiatric symptoms. Loneliness could put individuals at increased risk for the onset of psychiatric disorders.
Introduction
There is a concomitant rise in suicide rates with the prevalence of opioids involved in overdose deaths, especially among adolescents and young adults. However, there are limited studies ...on whether opioid use prospectively predicts suicidal behavior in youth.
Methods
Our sample included 183 psychiatric patients (18–30 years) admitted for a suicide attempt (SA), have current suicidal ideation (SI), and psychiatric controls without ideation or attempt (PC). Suicidal behavior was assessed using the Columbia Suicide Severity Rating Scale. We also recruited a healthy control group (HC; n = 40). Patients and controls were followed over a year. ANOVA, regression, and cox regression were used.
Results
Suicide attempt (β = 0.87, CI 0.1–1.6, p = 0.02) and SI (β = 0.75, CI 0.03–1.5, p = 0.04) were significantly more likely than HCs to have used opioids in the past year at baseline. Opioid use was associated with increased anxiety symptoms (β = 0.75, CI 0.001–1.5, p = 0.05), PTSD symptoms (β = 3.90, CI 1.1–6.7, p = 0.01), and aggression (β = 0.02, CI 0.01–0.04, p = 0.02). Opioid use in the month prior to hospitalization predicted SA at 6 months (OR = 1.87, CI 1.06–3.31, p = 0.032).
Conclusions
Opioid use is a proximal predictor for SA. These findings may help clinicians better identify patients at risk for suicidal behavior, allowing for more personalized treatment approaches.
PDF
